178 related articles for article (PubMed ID: 36938744)
21. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.
Navarrete-Opazo AA; Gonzalez W; Nahuelhual P
Arch Phys Med Rehabil; 2016 Apr; 97(4):604-618. PubMed ID: 26321489
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury.
Yoon YK; Lee KC; Cho HE; Chae M; Chang JW; Chang WS; Cho SR
Medicine (Baltimore); 2017 Aug; 96(34):e7472. PubMed ID: 28834868
[TBL] [Abstract][Full Text] [Related]
23. Surgical Tone Reduction in Cerebral Palsy.
Thomas SP; Addison AP; Curry DJ
Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):91-105. PubMed ID: 31760996
[TBL] [Abstract][Full Text] [Related]
24. Baclofen in the treatment of cerebral palsy.
Albright AL
J Child Neurol; 1996 Mar; 11(2):77-83. PubMed ID: 8881981
[TBL] [Abstract][Full Text] [Related]
25. CNS adverse effects of intrathecal baclofen treatment for spasticity in children with cerebral palsy and epilepsy: a case report.
De Rinaldis M; Gallo I; Oliva MC; Trabacca A
Neurol Sci; 2023 Jul; 44(7):2609-2611. PubMed ID: 36933098
[No Abstract] [Full Text] [Related]
26. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.
Van Schaeybroeck P; Nuttin B; Lagae L; Schrijvers E; Borghgraef C; Feys P
Neurosurgery; 2000 Mar; 46(3):603-9; discussion 609-12. PubMed ID: 10719857
[TBL] [Abstract][Full Text] [Related]
27. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
28. A critical evaluation of oral baclofen in pediatric patients with cerebral palsy.
McLaughlin MJ; Fisher MT
J Pediatr Rehabil Med; 2023; 16(1):3-9. PubMed ID: 36872802
[No Abstract] [Full Text] [Related]
29. Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.
Pittelkow TP; Bendel MA; Lueders DR; Beck LA; Pingree MJ; Hoelzer BC
Clin Neurol Neurosurg; 2018 Aug; 171():163-167. PubMed ID: 29913361
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal Baclofen Therapy-Practical Approach: Clinical Benefits and Complication Management.
Winter G; Beni-Adani L; Ben-Pazi H
J Child Neurol; 2018 Oct; 33(11):734-741. PubMed ID: 30009656
[TBL] [Abstract][Full Text] [Related]
31. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
Charles PD; Gill CE; Taylor HM; Putman MS; Blair CR; Roberts AG; Ayers GD; Konrad PE
Mov Disord; 2010 Mar; 25(4):466-73. PubMed ID: 20131401
[TBL] [Abstract][Full Text] [Related]
32. The management of cerebral palsy: subjectivity and a conundrum.
Bodensteiner JB
J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
[No Abstract] [Full Text] [Related]
33. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
Hasnat MJ; Rice JE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
[TBL] [Abstract][Full Text] [Related]
34. Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting.
Gburek-Augustat J; Krause M; Bernhard M; Sorge I; Gräfe D; Siekmeyer M; Nestler U; Merkenschlager A
Childs Nerv Syst; 2021 Aug; 37(8):2597-2604. PubMed ID: 33834279
[TBL] [Abstract][Full Text] [Related]
35. Scoliosis, spinal fusion, and intrathecal baclofen pump implantation.
Scannell B; Yaszay B
Phys Med Rehabil Clin N Am; 2015 Feb; 26(1):79-88. PubMed ID: 25479781
[TBL] [Abstract][Full Text] [Related]
36. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
; Delgado MR; Hirtz D; Aisen M; Ashwal S; Fehlings DL; McLaughlin J; Morrison LA; Shrader MW; Tilton A; Vargus-Adams J
Neurology; 2010 Jan; 74(4):336-43. PubMed ID: 20101040
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal baclofen in cerebral palsy movement disorders.
Albright AL
J Child Neurol; 1996 Nov; 11 Suppl 1():S29-35. PubMed ID: 8959459
[TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapy of spasticity in children with cerebral palsy.
Chung CY; Chen CL; Wong AM
J Formos Med Assoc; 2011 Apr; 110(4):215-22. PubMed ID: 21540003
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.
Krach LE
J Child Neurol; 2001 Jan; 16(1):31-6. PubMed ID: 11225954
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
